Literature DB >> 15278467

Dose-response relation and time course of action of pipecuronium in patients anesthetized with nitrous oxide and sevoflurane.

N Ueda1, Y Masuda, T Muteki, K Ohishi, K Tayama, N Yamashita.   

Abstract

The dose-response relation of pipecuronium, the time course of its neuromuscular blocking effects, and the reversibility of the residual block by neostigmine have been investigated in patients under sevoflurane/N2O Anesthesia using a neuromuscular transmission analyzer (Accelograph, Biometer, Denmark). After an initial dose of pipecuronium (0.04 mg.kg(-1), i.v.), the maximum block rate, onset time, the time from administration until 25% recovery and 50% recovery of control twitch height of the first response to train-of-four nerve stimulation and the interval time of administration of maintenance dose (0.005 mg.kg(-1), i.v.) were 93.7 +/- 7.68%, 5.0 +/- 1.84, 55.4 +/- 23.92, 73.0 +/- 29.44 and 38.7 +/- 15.50 minutes, respectively. The average intubation score (excellent; 0, good; 1 fair; 2, poor; 3) was 0.63 +/- 0.56 at the level of 95.88 +/- 5.06% block. Neostigmine (1.5 mg) promptly reversed the residual neuromuscular blockade induced by pipecuronium (reversal time: 10.1 +/- 2.98 minutes). No side effects attributable to pipecuronium was seen in this study. In conclusion, pipecuronium is a very useful nondepolarizing neuromuscular blocking agent especially for moderately long surgical procedure over 4-5 hours.

Entities:  

Year:  1993        PMID: 15278467     DOI: 10.1007/s0054030070151

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  6 in total

1.  What anesthesiologist should know about neuromuscular monitoring today?

Authors:  N Ueda; T Muteki; H Tsuda
Journal:  J Anesth       Date:  1992-04       Impact factor: 2.078

2.  Accelerated reversal of pancuronium blockade with divided administration of neostigmine.

Authors:  S Inoue; N Ueda; H Tsuda; T Muteki
Journal:  J Anesth       Date:  1989-09-01       Impact factor: 2.078

3.  Clinical assessment of a new neuromuscular transmission monitoring system (ACCELOGRAPH--a comparison with the conventional method.

Authors:  N Ueda; T Muteki; A Poulsen; J L-Espensen
Journal:  J Anesth       Date:  1989-03-01       Impact factor: 2.078

4.  Clinical pharmacology of ORG NC45 (NorcuronTM): a new nondepolarizing muscle relaxant.

Authors:  M R Fahey; R B Morris; R D Miller; Y J Sohn; R Cronnelly; P Gencarelli
Journal:  Anesthesiology       Date:  1981-07       Impact factor: 7.892

5.  Posttetanic count (PTC): a new method of evaluating an intense nondepolarizing neuromuscular blockade.

Authors:  J Viby-Mogensen; P Howardy-Hansen; B Chraemmer-Jørgensen; H Ording; J Engbaek; A Nielsen
Journal:  Anesthesiology       Date:  1981-10       Impact factor: 7.892

6.  Dose-response relation and time course of action of pipecuronium bromide in humans anesthetized with nitrous oxide and isoflurane, halothane, or droperidol and fentanyl.

Authors:  J M Wierda; F J Richardson; S Agoston
Journal:  Anesth Analg       Date:  1989-03       Impact factor: 5.108

  6 in total
  1 in total

Review 1.  Sevoflurance: approaching the ideal inhalational anesthetic. a pharmacologic, pharmacoeconomic, and clinical review.

Authors:  L Delgado-Herrera; R D Ostroff; S A Rogers
Journal:  CNS Drug Rev       Date:  2001
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.